Travaux scientifiques

Prof. Dr. Ömer Yiğiner

80 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. 1.The Effects of Female Sex Hormones on Ventricular Premature Beats and Repolarization Parameters in Physiological Menstrual Cycle. Dogan M, Yiginer O, Uz O, Kucuk U, Degirmencioglu G, Isilak Z, Uzun M, Davulcu E.Pacing Clin Electrophysiol. 2016 Feb 4. doi: 10.1111/pace.12821. [Epub ahead of print]

    Source : page de profil sur medicana.com.tr

  2. 2.The importance of visceral adipose tissue as a scale for assessing the metabolic syndrome and obesity. Ozcelik F, Yiginer O, Dogan M, Tokatli A. Eur Rev Med Pharmacol Sci. 2016 Jun;20(12):2475

    Source : page de profil sur medicana.com.tr

  3. 3.The use of endogenous substances in the evaluation of renal function in various clinical situations. Ozcelik F, Yiginer O. Eur J Gastroenterol Hepatol. 2016 May;28(5):606. doi: 10.1097/MEG.0000000000000577

    Source : page de profil sur medicana.com.tr

  4. 4.Transmural dispersion of repolarization: a complementary index for cardiac inhomogeneity. Dogan M, Yiginer O, Degirmencioglu G, Un H. J Geriatr Cardiol. 2016 Jan;13(1):99-100. doi: 10.11909/j.issn.1671-5411.2016.01.012

    Source : page de profil sur medicana.com.tr

  5. 5.The Relationship Between Serum Uric Acid Levels and The Major Risk Factors for The Development of Non-Alcoholic Fatty Liver Disease.Ozcelik F, Yiginer O.Liver Int. 2016 Jan 20.

    Source : page de profil sur medicana.com.tr

  6. 6.Relationship between thrombocytopenia and extrahepatic metastasis of hepatocellular carcinoma: a different perspective.Ozcelik F, Yiginer O, Özgün A.Liver Int. 2016 Jan 20

    Source : page de profil sur medicana.com.tr

  7. 7.Paroxysmal atrial fibrillation and related thromboembolism may be a hidden factor in the development of dementia.Tokatli A, Yiginer O, Ozmen N, Uzun M, Kilicaslan F. Psychogeriatrics. 2016 Jan 18. doi: 10.1111/psyg.12186. [Epub ahead of print] No abstract available.

    Source : page de profil sur medicana.com.tr

  8. 8.Heart rate correction should be kept in mind during measurements of ventricular repolarization parameters.Dogan M, Yiginer O, Un H, Dagasan I.Acta Anaesthesiol Belg. 2015;66(3):101.

    Source : page de profil sur medicana.com.tr

  9. 9.Quantitative assessment of cardiac electrical heterogeneity in patients with polycystic ovary syndrome by transmural dispersion of repolarization and atrial electromechanical coupling. Tokatli A, Yiginer O.Eur Rev Med Pharmacol Sci. 2015 Dec;19(24):4688. No abstract available.

    Source : page de profil sur medicana.com.tr

  10. 10.Independently from mitral regurgitation, Barlow disease may cause left ventricular enlargement and thereby anticipation of surgery.Yiginer O, Tokatli A, Dogan M, Ozmen N. Ital J Anat Embryol. 2015;120(1):1-2. No abstract available.

    Source : page de profil sur medicana.com.tr

  11. 11.Prolonged Tp-e Interval, Tp-e/QT Ratio and Tp-e/QTc Ratio in Patients with Type 2 Diabetes Mellitus.Tokatli A, Kiliçaslan F, Alis M, Yiginer O, Uzun M.Endocrinol Metab (Seoul). 2015 Dec 9. [Epub ahead of print]

    Source : page de profil sur medicana.com.tr

  12. 12.Altered atrial conduction in postoperative atrial fibrillation.Tokatli A, Yiginer O.Int J Cardiol. 2016 Jan 15;203:945-6.

    Source : page de profil sur medicana.com.tr

  13. 13.Atrial electromechanical coupling parameters should be kept in mind during the assessment of atrial arrhythmia risk.Yiginer O, Tokatli A, Gokhan D, Dogan M.Eur Rev Med Pharmacol Sci. 2015 Nov;19(21):3989-90. No abstract available.

    Source : page de profil sur medicana.com.tr

  14. 14.Effect of oxidative stress on ventricular repolarization in patients with type 2 diabetes: non-invasive quantification via transmural dispersion of repolarization.Tokatli A, Yiginer O, Kilicaslan F.Endocrine. 2015 Nov 9. [Epub ahead of print] No abstract available.

    Source : page de profil sur medicana.com.tr

  15. 15.Atrial fibrillation may be a hidden factor for the development of cognitive impairment in patients with heart failure.Yiginer O, Tokatli A, Dogan M, Erdal E.J Geriatr Cardiol. 2015 Sep;12(5):590. doi: 10.11909/j.issn.1671-5411.2015.05.007. No abstract available.

    Source : page de profil sur medicana.com.tr

  16. 16.Transmural dispersion of repolarization and atrial electromechanical coupling: complementary indices for quantifying cardiac electrical heterogeneity in patients with conversion disorder.Tokatli A, Yiginer O, Degirmencioglu G, Kilicaslan F, Uzun M.Ther Clin Risk Manag. 2015 Jul 20;11:1077-80.

    Source : page de profil sur medicana.com.tr

  17. 17.An Issue Waiting to be Clarified: Effects of the QT Prolonging Drugs on Tp-e Interval. Yiginer O, Dogan M, Erdal E.Arq Bras Cardiol. 2015 Jun;104(6):507

    Source : page de profil sur medicana.com.tr

  18. 18.A step forward parameter for the effects of transcatheter aortic valve implantation: transmural dispersion of repolarization.Tezcan M, Yiğiner Ö, Doğan M, Değirmencioğlu G.J Geriatr Cardiol. 2015 May;12(3):326-8.

    Source : page de profil sur medicana.com.tr

  19. 19.Effect of cardiac rehabilitation on ventricular repolarization in patients with type 2 diabetes and coronary heart disease: Non-invasive quantification via transmural dispersion of repolarization.Tokatli A, Yiginer O, Kilicaslan F, Uzun M.Heart Lung. 2015 Sep-Oct;44(5):459-60.

    Source : page de profil sur medicana.com.tr

  20. 20.Efficiency of quantification of cardiac electrical heterogeneity: via QT dispersion, transmural dispersion, or both.Tokatli A, Yiginer O, Haholu A, Uzun M. Biol Sport. 2015 Jun;32(2):175-6. doi: 10.5604/20831862.1145079. Epub 2015 Mar 17.

    Source : page de profil sur medicana.com.tr

  21. 21.The combination of hydralazine and isosorbide dinitrate: the only antioxidant treatment recommended in the guidelines.Yiginer O, Tokatli A, Haholu A, Ozmen N. Eur Rev Med Pharmacol Sci. 2015 May;19(10):1745-6

    Source : page de profil sur medicana.com.tr

  22. 22.Twin hearts: identical anomalous coronary origin, individual vasculature Tezcan M, Yiğiner Ö, Cebeci BS.Anatol J Cardiol. 2015 Apr 1;15(4):

    Source : page de profil sur medicana.com.tr

  23. 23.Frequently occurring Torsades de pointes attacks in an old patient on solifenacin therapy and management strategy.Özmen N, Yiğiner Ö, Ün H, Bıçakçı B.Anatol J Cardiol. 2015 Apr;15(4):342-3.

    Source : page de profil sur medicana.com.tr

  24. 24.Dulce RA, Yiginer O, Gonzalez DR, Goss G, Feng N, Zheng M, Hare JM. Hydralazine and Organic Nitrates Restore Impaired Excitation-Contraction Coupling by Reducing Calcium Leak Associated with Nitroso-Redox Imbalance. J Biol Chem. 2013 Jan 15. [Epub ahead of print)

    Source : page de profil sur medicana.com.tr

  25. 25.Melatonin protects against ischemic heart failure in rats. Sehirli AO, Koyun D, Tetik S, Ozsavcı D, Yiğiner O, Cetinel S, Tok OE, Kaya Z, Akkiprik M, Kılıç E, Sener G. J Pineal Res. 2013 Mar 15

    Source : page de profil sur medicana.com.tr

  26. 26.Yalcin M, Kardesoglu E, Aparci M, Isilak Z, Uz O, Yiginer O, Ozmen N, Cingozbay BY, Uzun M, Cebeci BS Cardiovascular risk scores for coronary atherosclerosis Acta Cardiol. 2012 Oct;67(5):557-63

    Source : page de profil sur medicana.com.tr

  27. 27.Yiginer O, Ozcelik F, Inanc T, Aparci M, Ozmen N, Cingozbay BY, Kardesoglu E, Suleymanoglu S, Sener G, Cebeci BS. Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome. Clin Res Cardiol. 2008 May;97(5):334-40.

    Source : page de profil sur medicana.com.tr

  28. 28.Yiginer O, Keser N, Ozmen N, Tokatli A, Kardesoglu E, Isilak Z, Uz O, Uzun M. Classic mitral valve prolapse causes enlargement in left ventricle even in the absence of significant mitral regurgitation. Echocardiography. 2012 Feb;29(2):123-9.

    Source : page de profil sur medicana.com.tr

  29. 29.Yiginer O, Bas S, Pocan S, Yildiz A, Alibek S. Incidental findings of cardiac MSCT: who might benefit from scanning the entire thorax on Ca score imaging? Int J Cardiol. 2010 Apr 15;140(2):239-41.

    Source : page de profil sur medicana.com.tr

  30. 30.Yiginer O, Uzun M, Yilmaz Cingozbay B, Kardesoglu E, Atalay M, Isilak Z, Uz O, Keser N, Sitki Cebeci B. A simplified proximal isovelocity surface area method for mitral valve area calculation in mitral stenosis: not requiring angle correction and calculator. Med Glas Ljek komore Zenicko-doboj kantona. 2011 Aug;8(2):197-202.

    Source : page de profil sur medicana.com.tr

  31. 31.Yiginer O, Kilicaslan F, Aparci M, Isilak Z, Uz O, Bayrak F, Eroglu E, Uzun M, Kardesoglu E, Kirilmaz A, Cebeci BS. Advanced Age, Female Gender and Delay in Pacemaker Implantation May Cause TdP in Patients With Complete Atrioventricular Block. Indian Pacing Electrophysiol J. 2010 Oct 31;10(10):454-63.

    Source : page de profil sur medicana.com.tr

  32. 32.Yiğiner O, Ozmen N, Ozçelik F, Inanç T, Kardeşoğlu E, Uz O, Işılak Z, Aparcı M, Sahin I, Arslan E, Cebeci BS. [Adherence to statin therapy and LDL cholesterol goal attainment in type 2 diabetics and secondary prevention patients: the role of education and knowledge].Turk Kardiyol Dern Ars. 2010 Dec;38(8):544-50.

    Source : page de profil sur medicana.com.tr

  33. 33.Yiginer O, Bas S, Feray H. Demonstration of coronary-to-pulmonary fistula with MDCT and conventional angiography. Int J Cardiol. 2009 May 29;134(3):e126-8.

    Source : page de profil sur medicana.com.tr

  34. 34.Yiğiner O, Kardeşoğlu E, Uz O, Ozmen N, Cebeci BS. [Cardiac regenerative therapy: which type of cell will breast the tape?/Autologous stem cell therapy with surgical myocardial revascularization-The Rostock University experience].Anadolu Kardiyol Derg. 2011 May;11(3):277;

    Source : page de profil sur medicana.com.tr

  35. 35.Yiginer O, Uz O, Kardesoglu E, Tokatli A, Sildiroglu HO, Ozmen N. Noncompaction of the myocardium coexistent with vertebral hemangiomas. Tex Heart Inst J. 2011;38(2):212-3.

    Source : page de profil sur medicana.com.tr

  36. 36.Yiğiner O, Kılıçaslan F, Tokatlı A, Işılak Z. [Concealed Brugada syndrome that became apparent incidentally during atrial fibrillation therapy]. Turk Kardiyol Dern Ars. 2011

    Source : page de profil sur medicana.com.tr

  37. 37.Yiginer O, Kardesoglu E, Ozmen N, Aparci M, Cebeci BS. Complete resolution of very late stent thrombosis with systemic thrombolysis. J Cardiovasc Med (Hagerstown). 2011 Oct;12(10):765-7.

    Source : page de profil sur medicana.com.tr

  38. 38.Yiğiner O, Cingözbay BY, Uz O, Cebeci BS. An overlooked diagnosis on transthoracic echocardiography: apical hypertrophic cardiomyopathy. Turk Kardiyol Dern Ars. 2009 Dec;37(8):569-71.

    Source : page de profil sur medicana.com.tr

  39. 39.Yiğiner O, Ozçelik F, Aparci M, Işilak Z, Uz O. The beneficial effects of allopurinol in cardiology practice: decrease in uric acid and vascular oxidative stress/ the effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pilot study. Anadolu Kardiyol Derg. 2010 Jun;10(3):294-5; author reply 295-6.

    Source : page de profil sur medicana.com.tr

  40. 40.Kilicaslan F, Tokatli A, Ozdag F, Uzun M, Uz O, Isilak Z, Yiginer O, Yalcin M, Guney MS, Cebeci BS.Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio are prolonged in patients with moderate and severe obstructive sleep apnea. Pacing Clin Electrophysiol. 2012 Aug;35(8):966-72.

    Source : page de profil sur medicana.com.tr

  41. 41.Yıldırım M, Yiginer O, Uzun M, Yilmaz Cingozbay B, Sag C, Kutsi Kabul H, Uz O, Isilak Z, Kardesoglu E, Sitki Cebeci B.Aortic flow propagation velocity as an early predictor of high coronary risk in hypertensive patients.Med Glas Ljek komore Zenicko-doboj kantona. 2012 Feb;9(1):42-8.

    Source : page de profil sur medicana.com.tr

  42. 42.Işılak Z, Cay S, Yiğiner O, Uzun M. Biventricular noncompaction and mitral cleft.Anadolu Kardiyol Derg. 2012 Jun;12(4):361-2. doi: 10.5152/akd.2012.102.

    Source : page de profil sur medicana.com.tr

  43. 43.Isilak Z, Kardesoglu E, Aparci M, Uz O, Yalcin M, Yiginer O, Cingozbay BY, Uzun M. Comparison of clinical risk assessment systems in predicting three-vessel coronary artery disease and angiographic culprit lesion in patients with non-ST segment elevated myocardial infarction/unstable angina pectoris. Kardiol Pol. 2012;70(3):242-50.

    Source : page de profil sur medicana.com.tr

  44. 44.Ozcelik F, Arslan E, Serdar MA, Yiginer O, Oztosun M, Kayadibi H, Kurt I. A useful method for the detection of ethylenediaminetetraacetic Acid- and cold agglutinin-dependent pseudothrombocytopenia. Am J Med Sci. 2012 Nov;344(5):357-62.

    Source : page de profil sur medicana.com.tr

  45. 45.Ozmen N, Uz O, Cingözbay BY, Yiğiner O. [Successful percutaneous retrieval of a broken intravascular ultrasound catheter tip from the renal artery]. Turk Kardiyol Dern Ars. 2011 Sep;39(6):505-7.

    Source : page de profil sur medicana.com.tr

  46. 46.Uz O, Kardesoglu E, Tas D, Acar G, Isilak Z, Yiginer O, Aparci M, Cingozbay BY, Cebeci BS.CA-125 level is associated with right ventricular echocardiographic parameters in patients with COPD. South Med J. 2011 Sep;104(9):624-8.

    Source : page de profil sur medicana.com.tr

  47. 47.Kardesoglu E, Isilak Z, Uz O, Yiginer O.An independent prognostic factor for heart failure: sympathetic hyperactivity.Chin Med J (Engl). 2011 Apr;124(7):1118.

    Source : page de profil sur medicana.com.tr

  48. 48.Uz O, Kardesoglu E, Uzun M, Isilak Z, Yiginer O, Aparcı M, Ozmen N, Cebeci BS. Effect of position changes on myocardial velocity in healthy subjects evaluated by tissue Doppler echocardiography.Echocardiography. 2011 May;28(5):516-9.

    Source : page de profil sur medicana.com.tr

  49. 49.Kardesoglu E, Isilak Z, Uz O, Yiginer O. Ischemic conditioning: a current concept in reducing reperfusion injury. Chin Med J (Engl). 2011 Feb;124(3):480.

    Source : page de profil sur medicana.com.tr

  50. 50.Ozmen N, Guney MS, Togrul E, Yiginer O, Aparci M, Kardesoglu E, Cingozbay Y, Saracoglu M, Cebeci BS. Elastic characteristics of aorta in patients with epilepsy. Med Glas Ljek komore Zenicko-doboj kantona. 2011 Feb;8(1):15-8.

    Source : page de profil sur medicana.com.tr